Table 2. Univariate and multivariate analysis of survival in early-stage NSCLC patients.
Variable | Univariate Analysis | Multivariate Analysis | ||||
---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | |
KIAA1522 | ||||||
High vs. low expression | 2.304 | 1.489–3.567 | 0.00018 | 2.317 | 1.477–3.635 | 0.00025 |
Age | ||||||
≥60 vs. <60 | 2.006 | 1.254–3.207 | 0.004 | 2.082 | 1.269–3.415 | 0.004 |
Sex | ||||||
Male vs. female | 2.459 | 1.307–4.626 | 0.005 | 2.188 | 1.042–4.595 | 0.039 |
Tumor type | ||||||
SCC vs. ADC | 1.601 | 1.044–2.457 | 0.031 | 1.319 | 0.815–2.135 | 0.260 |
T status | ||||||
≤7 cm vs. >7 cm | 1.707 | 0.964–3.022 | 0.067 | |||
N status | ||||||
N0 vs. N1-3 | 1.528 | 0.983–2.377 | 0.060 | |||
Tumor differentiation | ||||||
Well vs. Moderate vs. poorly | 1.128 | 0.801–1.589 | 0.490 | |||
Gross pathology | ||||||
Central vs. peripheral | 1.511 | 0.989–2.308 | 0.056 | |||
Smoking history | ||||||
Non vs. current or former smoker | 2.010 | 1.167–3.461 | 0.012 | 1.006 | 0.518–1.952 | 0.986 |
HR = Hazard Ratio.